Chronic obstructive pulmonary disease COPD exacerbations

The most common causes of failure to wean include chronic obstructive pulmonary disease (COPD) exacerbations, neuromuscular diseases, h) oxic respiratory failure, post surgical complications (2), and heart failure. Weaning from the tracheostomy must consider the balance of respiratory muscle function and work of breathing. The work of breathing is determined by ventilatory demand, compliance of the lungs and chest wall, airway resistance, and intrinsic positive end-expiratory pressure (PEEPi). Adequacy of ventilatory drive and neuromechanical output can be assessed from the respiratory rate, airway occlusion pressure at 100 milliseconds (Po.i), maximum inspiratory pressure (MIP), and maximum voluntary ventilation (MW). 

The two most prevalent chronic inflammatory lung diseases are asthma and chronic obstructive pulmonary disease (COPD). These diseases are a major and increasing global health problem. Both asthma and COPD share some clinical features, such as increased airway obstruction, mucous hypersecretion, acute exacerbations and respiratory symptoms. Asthma and COPD are identified by the presence of chronic inflammation of the airways, which is controlled by the increased expression of inflammatory proteins, including cytokines, chemokines, receptors, enzymes and... 

Budesonide is a glucocortical steroid for the treatment of asthma, chronic obstructive pulmonary disease (COPD) and noninfectious rhinitis, and for the treatment and prevention of nasal polyposis. If is also used for Crohn disease (CD). At the same time budesonide is contraindicated as a primary treatment of sfafus asthmaticus or ofher acufe episodes of asthma when intensive measures are required. Also, treatment with an inhaled corticosteroid and long-acting bronchodilator is recommended for severe/very severe COPD patients with repeated exacerbations. 

One case report of SIADH was noted on day 2 of treatment with moxifloxacin for an acute exacerbation of chronic obstructive pulmonary disease (COPD). SIADH has many causes, some of which were potentially present in this patient however, careful monitoring for adverse events is recommended in all [62 ]. 

NIV is often an effective treatment for patients with acute respiratory failure, especially when secondary to exacerbation of chronic obstructive pulmonary disease (COPD) (24). NIV is also utilized for long-term ventilation (LTV) of patients with chronic respiratory failure due to thoracic restriction or NMD. It is used less frequently for COPD as there is only limited evidence of its long-term effectiveness in this condition (25). In stable patients, NIV is affected by the type of interface used (26). 

Abbreviations. MV, mechanical ventilation AECOPD, acute exacerbation of chronic obstructive pulmonary disease ALD, acute lung disease ALI, acute lung injury ARDS, acute respiratory distress syndrome CLD, chronic lung disease COPD, chronic obstructive pulmonary disease MOF, multiple organ failure NMD, neuromuscular disease NR, not reported. 

Accretion of a viscid mucus is the hallmark of the more chronic forms of obstructive pulmonary disease. The presence of the mucus exacerbates the pathology both by providing a mechanical block to the inspiration and expiration of air and by preventing topical drugs from reaching the distal bronchi. Although not universally accepted, therapy which will liquify the mucus so that It can be expectorated should have a place in the treatment of COPD. Sulfhydryl drugs such as N-acetylcysteine are available for this use. 

---